Citadel Advisors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,054
| Closed | -$37K | – | 7196 |
|
|
2022
Q1 | $37K | Sell |
3,054
-692
| -18% | -$8.38K | ﹤0.01% | 6004 |
|
|
2021
Q4 | $39K | Buy |
3,746
+1,978
| +112% | +$20.6K | ﹤0.01% | 6221 |
|
|
2021
Q3 | $57K | Sell |
1,768
-18
| -1% | -$580 | ﹤0.01% | 6078 |
|
|
2021
Q2 | $76K | Buy |
+1,786
| New | +$76K | ﹤0.01% | 6076 |
|
|
2020
Q4 | – | Sell |
-293
| Closed | -$12K | – | 5745 |
|
|
2020
Q3 | $12K | Buy |
+293
| New | +$12K | ﹤0.01% | 4575 |
|
|
2019
Q3 | – | Sell |
-80
| Closed | -$21K | – | 5253 |
|
|
2019
Q2 | $21K | Sell |
80
-69
| -46% | -$18.1K | ﹤0.01% | 4494 |
|
|
2019
Q1 | $56K | Buy |
149
+63
| +73% | +$23.7K | ﹤0.01% | 4209 |
|
|
2018
Q4 | $32K | Sell |
86
-17
| -17% | -$6.33K | ﹤0.01% | 4169 |
|
|
2018
Q3 | $44K | Buy |
+103
| New | +$44K | ﹤0.01% | 4020 |
|
|
2018
Q2 | – | Sell |
-57
| Closed | -$26K | – | 4689 |
|
|
2018
Q1 | $26K | Buy |
+57
| New | +$26K | ﹤0.01% | 3842 |
|
|
2017
Q3 | – | Sell |
-78
| Closed | -$67K | – | 4236 |
|
|
2017
Q2 | $67K | Buy |
+78
| New | +$67K | ﹤0.01% | 3350 |
|
|
2016
Q3 | – | Sell |
-44
| Closed | -$63K | – | 4206 |
|
|
2016
Q2 | $63K | Buy |
44
+30
| +214% | +$43K | ﹤0.01% | 3026 |
|
|
2016
Q1 | $17K | Buy |
+14
| New | +$17K | ﹤0.01% | 3190 |
|
|
2015
Q3 | – | Sell |
-3
| Closed | -$6K | – | 4367 |
|
|
2015
Q2 | $6K | Buy |
+3
| New | +$6K | ﹤0.01% | 3735 |
|
|
2015
Q1 | – | Sell |
-5
| Closed | -$17K | – | 4110 |
|
|
2014
Q4 | $17K | Buy |
+5
| New | +$17K | ﹤0.01% | 3682 |
|
|
2014
Q3 | – | Sell |
-12
| Closed | -$45K | – | 3807 |
|
|
2014
Q2 | $45K | Buy |
12
+10
| +500% | +$37.5K | ﹤0.01% | 3139 |
|
|
2014
Q1 | $8K | Sell |
2
-8
| -80% | -$32K | ﹤0.01% | 3532 |
|
|
2013
Q4 | $39K | Sell |
10
-38
| -79% | -$148K | ﹤0.01% | 2788 |
|
|
2013
Q3 | $189K | Buy |
48
+46
| +2,300% | +$181K | ﹤0.01% | 2315 |
|
|
2013
Q2 | $22K | Buy |
+2
| New | +$22K | ﹤0.01% | 2626 |
|